Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey

↑ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 398 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (398 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 398 days

Description

This study covers the world outlook for neurodegenerative diseases treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of neurodegenerative diseases treatments as including all commonly understood products and/or services falling within this broad category, such as treatments for diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS) and drugs which reduce motor symptoms of Parkinson's, combat orthostatic hypertension in Parkinson's, maximize amyotrophic lateral sclerosis (ALS) patients' survival time and functional lifespan, and treat overall motor symptoms of Huntington's (HD) while having a high tolerability, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott Labs, Amgen, Bayer, GlaxoSmithKline, Pfizer, and Takeda Pharmaceuticals. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZM1CQC8
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 06 May 2024

Gone for 318 days. Could come back at any time — we're watching for you.

The 2025-2030 World Outlook for Neurodegenerative Diseases Treatments

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like